Atsushi Yasumoto

Atsushi Yasumoto is the President of Nexredge Inc., a pharmaceutical consulting company.3 As the leader of this organization, he specializes in creating and implementing strategic project plans and supporting the launch of new products in the pharmaceutical industry.3

Yasumoto has been active on LinkedIn, sharing updates about his company and industry developments. In January 2019, he posted about Nexredge Inc. moving to a new head office, indicating the company's growth and ongoing challenges.1 More recently, in December 2023, he shared information about a new type of mRNA vaccine for COVID-19 that had been approved in Japan, demonstrating his engagement with current pharmaceutical trends.2

Nexredge Inc., under Yasumoto's leadership, appears to be involved in various aspects of pharmaceutical consulting. The company likely provides strategic advice and support to other businesses in the pharmaceutical sector, leveraging Yasumoto's expertise in product launches and project management.3

Yasumoto's professional network on LinkedIn includes connections to other professionals in the pharmaceutical and biotechnology industries. His engagement with posts about drug repurposing and orphan drug development suggests an interest in innovative approaches to drug development and rare diseases.4